Creatine for the Treatment of Depression

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Depressed mood is a significant public health concern, often linked to major depressive disorder and bipolar disorder.
• Conventional antidepressant treatments are ineffective for a substantial patient population, highlighting the need for novel therapeutic strategies.
• Existing interventions for treatment-refractory depression are not widely accessible, necessitating the development of new approaches.

Purpose of the Study:

• To explore novel antidepressant strategies targeting distinct physiological pathways.
• To investigate the role of brain energy metabolism disruptions in depression.
• To evaluate the potential of creatine as an antidepressant agent.

Main Methods:

• Review of evidence from human neuroimaging, genetics, epidemiology, and animal studies.
• Analysis of creatine's biochemical properties related to energy metabolism.
• Examination of early clinical trial data on creatine's efficacy in depression.

Main Results:

• Growing evidence implicates disruptions in brain energy production, storage, and utilization in depression.
• Creatine, a readily available nutritional supplement, may help correct these metabolic disruptions.
• Preliminary clinical trials suggest creatine may possess antidepressant properties.

Conclusions:

• Targeting brain energy metabolism represents a promising avenue for novel antidepressant therapies.
• Creatine's potential to improve energy metabolism deficits warrants further investigation as a treatment for depression.
• Further research and clinical trials are needed to establish creatine's efficacy and safety as an antidepressant.